![Nicolas Roelofs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Roelofs
Directeur/Membre du Conseil chez
SEER, INC.
Fortune : 49 847 $ au 31/05/2026
Profil
Nicolas Henry Roelofs is currently Chairman at Accelerate Technologies Pte Ltd., Director at LGC-Group LLC, Axion BioSystems, Inc., Hytest Oy, Thermo Fisher Scientific Blade I Ltd., and Biopath Ventures.
He is Non-Executive Director at LGC Ltd. since 2016, Director at One BioMed Pte Ltd. since 2017, Director at M51 Topco, Inc. since 2022, and Lead Independent Director at Seer, Inc. (California) since 2024.
Former roles include Chairman at BlueBee Holding BV (2016–2020), Scale Biosciences, Inc. (2021–2025), and Sengenics Corp.
LLC (2020–2024).
Served as Vice Chairman and Director at Embracing Future Holdings Ltd., Director at M51 Topco, Inc. (2022–2025), Independent Director at Boreal Genomics, Inc. (2014–2021), Director at Life Technologies Clinical Services Lab, Inc. (1997–2001), The Binding Site Group Ltd. (2014–2023), InSilixa, Inc. (2015–2021), Clear Labs, Inc. (2014–2019), DA32 Life Science Tech Acquisition Corp.
(2021–2023), and Board Member at SeraCare Life Sciences, Inc. (2014–2018).
Held positions at LGC Science Group Holdings Ltd., Olink Holding AB, and Summa Equity AB. Worked at Bio-Rad Laboratories, Inc. as Operations Officer-Life Sciences Group (2006), Agilent Technologies, Inc. as President-Life Sciences Group & Senior VP (2012–2013), Stratagene Corp.
as Chief Operating Officer (2004), and Baxter International, Inc. as Development Manager (1989–1997).
Education includes a doctorate from The University of Nevada, Reno (1987), a graduate degree from Iowa State University (1983), and an undergraduate degree from Simpson College (1979).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SEER, INC. CLASS A 0,05% | 31/03/2026 | 26 656 ( 0,05% ) | 49 847 $ | 31/05/2026 |
Postes actifs de Nicolas Roelofs
| Sociétés | Poste | Début |
|---|---|---|
| SEER, INC. | Directeur/Membre du Conseil | 13/08/2024 |
LGC-Group LLC
 LGC-Group LLC Investment ManagersFinance Provides financial advisory services | Directeur/Membre du Conseil | - |
Biopath Ventures
 Biopath Ventures Investment ManagersFinance Biopath ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Axion BioSystems, Inc.
 Axion BioSystems, Inc. Medical SpecialtiesHealth Technology Develops life science instrumentation and medical diagnostic equipment | Directeur/Membre du Conseil | - |
Exploit Technologies Pte Ltd.
 Exploit Technologies Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property portfolio company | Président | - |
M51 Topco, Inc.
 M51 Topco, Inc. Packaged SoftwareTechnology Services Develops medicine software that connect healthcare and life sciences | Directeur/Membre du Conseil | 01/07/2022 |
Hytest Oy
 Hytest Oy BiotechnologyHealth Technology Manufactures biological products | Directeur/Membre du Conseil | - |
One BioMed Pte Ltd.
 One BioMed Pte Ltd. Medical/Nursing ServicesHealth Services Provides integrated molecular diagnostics services | Directeur/Membre du Conseil | 01/07/2017 |
LGC Ltd.
 LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Directeur/Membre du Conseil | 01/04/2016 |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ ░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Nicolas Roelofs
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Nicolas Roelofs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Bio-Rad Laboratories, Inc.
 Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
LGC-Group LLC
LGC-Group LLC Investment ManagersFinance Provides financial advisory services | Finance |
Axion BioSystems, Inc.
Axion BioSystems, Inc. Medical SpecialtiesHealth Technology Develops life science instrumentation and medical diagnostic equipment | Health Technology |
Boreal Genomics, Inc.
 Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Health Technology |
Nordic Capital Ltd.
 Nordic Capital Ltd. Investment ManagersFinance Nordic Capital invests in mid-market companies located in North Europe and North America with an enterprise of EUR 50 - 500 million. The firm focuses on healthcare, technology & payments, financial services and services & industrial sectors. It provides financing for buyout transactions. | Finance |
Stratagene Corp.
 Stratagene Corp. Medical SpecialtiesHealth Technology Researches and develops diagnostic products | Health Technology |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simpson College
 Simpson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LGC Ltd.
LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Commercial Services |
Life Technologies Clinical Services Lab, Inc.
 Life Technologies Clinical Services Lab, Inc. Medical/Nursing ServicesHealth Services Provides personalized, preventive health and wellness services | Health Services |
Exploit Technologies Pte Ltd.
Exploit Technologies Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property portfolio company | Commercial Services |
The Binding Site Group Ltd.
 The Binding Site Group Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture and distribution of tests used for the detection of cancers & immune disorders | Commercial Services |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Manufactures biological products | Health Technology |
The University of Nevada, Reno
 The University of Nevada, Reno Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSilixa, Inc.
 InSilixa, Inc. SemiconductorsElectronic Technology Develops molecular diagnostic platform | Electronic Technology |
Clear Labs, Inc.
 Clear Labs, Inc. Food: Major DiversifiedConsumer Non-Durables Provides services related to food quality | Consumer Non-Durables |
BlueBee Holding BV
 BlueBee Holding BV Medical SpecialtiesHealth Technology Provides diagnostic tools and components to clinicians | Health Technology |
Summa Equity AB
 Summa Equity AB Investment ManagersFinance Summa Equity invests in mid-market companies located in the Nordic countries. The firm targets companies operating in the fields of circularity, sustainable food, energy transition and tech-enabled resilience sectors. It provides financing for buyout and growth capital transactions with an investments size of EUR 40 - 200 million. | Finance |
LGC Science Group Holdings Ltd.
 LGC Science Group Holdings Ltd. MiscellaneousMiscellaneous Operates as non classifiable establishments | Miscellaneous |
Seer, Inc. (California)
 Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
Biolidics Ltd.
 Biolidics Ltd. BiotechnologyHealth Technology Develops cell enrichment systems | Health Technology |
Thermo Fisher Scientific Blade I Ltd.
 Thermo Fisher Scientific Blade I Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Commercial Services |
One BioMed Pte Ltd.
One BioMed Pte Ltd. Medical/Nursing ServicesHealth Services Provides integrated molecular diagnostics services | Health Services |
Biopath Ventures
Biopath Ventures Investment ManagersFinance Biopath ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
Scale Biosciences, Inc.
 Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Develops single cell sequencing library preparation technology and single-cell analysis solutions | Health Technology |
DA32 Life Science Tech Acquisition Corp.
 DA32 Life Science Tech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sengenics Corp LLC | |
M51 Topco, Inc.
M51 Topco, Inc. Packaged SoftwareTechnology Services Develops medicine software that connect healthcare and life sciences | Technology Services |
